Agenus, Inc. (AGEN)
4.82
+0.10
(+2.12%)
USD |
NASDAQ |
Apr 15, 16:00
4.82
0.00 (0.00%)
After-Hours: 20:00
Agenus Research and Development Expense (Annual) : 79.34M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Protalix Biotherapeutics, Inc. | 19.05M |
| CervoMed, Inc. | 21.82M |
| Curis, Inc. | 28.25M |
| Plus Therapeutics, Inc. | 8.379M |
| Windtree Therapeutics, Inc. | 16.19M |